CYBB and Alzheimer disease: Accordingly, in a mouse model with increased β-amyloid peptide accumulation, NOX2 deficiency improves the outcome of AD: neuronal oxidative stress and behavioral deficits strongly decrease even if β-amyloid deposits still persist, indicating that microglial NOX2 is not the cause of AD but a key amplifier of its deleterious effects [295,296].